CrossRef

Acute kidney injury and COVID-19

The Egyptian Journal of Internal Medicine 33(1) (2021)

Hayder M. Al-kuraishy; Ali I. Al-Gareeb

Antidepressants and type 2 diabetes: highways to knowns and unknowns

Diabetology & Metabolic Syndrome 15(1) (2023)

Nahi Sabih Alruwaili; Hayder M. Al-Kuraishy; Ali I. Al-Gareeb; Ali K. Albuhadily; Amany E. Ragab; Ahmad Awad Alenazi; Athanasios Alexiou; Marios Papadakis; Gaber El-Saber Batiha

Unraveling COVID-19: A Global Health Crisis and Ongoing Research

Futuristic Biotechnology (2023)

Osama Alam; Muhammad Ahmad; Munib Qureshi; Marina Gul; Naveed Khan; Abdul Samad; Zewran Khan; Syed Atiq; Arsalan Iqbal; Asim Ullah

Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment

NeuroMolecular Medicine 27(1) (2025)

Saad Misfer Alqahtani; Hayder M. Al-kuraishy; Ali I. Al Gareeb; Ali K. Albuhadily; Athanasios Alexiou; Marios Papadakis; Loah R. Hemeda; Safaa A. Faheem; Gaber El-Saber Batiha

The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19

Journal of Biochemical and Molecular Toxicology 38(1) (2024)

Hayder M. Al‐kuraishy; Ali I. Al‐Gareeb; Omayma A. Eldahshan; Yasmine M. Abdelkhalek; Magdy El dahshan; Eman A. Ahmed; Jean‐Marc Sabatier; Gaber E.‐S. Batiha

A cross-sectional pilot study on COVID-19 disease pattern, recovery status and effect of co-morbidities in Bangladesh

African Journal of Pharmacy and Pharmacology 15(5) (2021)

Monirul Islam Md.; Shahriar Saimon; Jannat Koly Fahima; Kabir Shaila; Asad Choudhury Abu; Ahmed Chowdhury Jakir; Rafat Tahsin Md.; Shah Amran Md.

Pregnancy and COVID-19: high or low risk of vertical transmission

Clinical and Experimental Medicine 23(4) (2022)

Hayder M. Al-kuraishy; Ali I. Al-Gareeb; Nisreen Khalid Aref Albezrah; Haitham Ahmed Bahaa; Maisra M. El-Bouseary; Athanasios Alexiou; Shatha Hallal Al-Ziyadi; Gaber El-Saber Batiha

Untitled

Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review

Frontiers in Public Health 9 (2021)

Amany Magdy Beshbishy; Victor B. Oti; Diaa E. Hussein; Ibrahim F. Rehan; Oluyomi S. Adeyemi; Nallely Rivero-Perez; Adrian Zaragoza-Bastida; Muhammad Ajmal Shah; Khaled Abouelezz; Helal F. Hetta; Natália Cruz-Martins; Gaber El-Saber Batiha

Immunological interactions in helminths‐SARS CoV‐2 coinfection: Could old enemy be a friend today?

Parasite Immunology 45(5) (2023)

Mohammed Alrouji; Hayder M. Al‐Kuraishy; Ali I. Al‐Gareeb; Heba Elhadad; Athanasios Alexiou; Marios Papadakis; Hanan A. Ogaly; Ahmed M. Elgazzar; Gaber El‐Saber Batiha

COVID-19 and phosphodiesterase enzyme type 5 inhibitors

Journal of Microscopy and Ultrastructure 8(4) (2020)

HayderM Al-Kuraishy; AliI Al-Gareeb; MarwaS Al-Niemi; AliK Al-Buhadily; NasserA Al-Harchan; Claire Lugnier

PDE5 inhibitors: breaking new grounds in the treatment of COVID-19

Drug Metabolism and Personalized Therapy (2023)

Ryan Varghese; Gargi Digholkar; Jainam Karsiya; Sahil Salvi; Jeenam Shah; Dileep Kumar; Rohit Sharma

COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?

Current Molecular Pharmacology 16(4) (2023)

Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Gomaa Mostafa-Hedeab; Rupal Dubey; Pranav Kumar Prabhakar; Gaber El-Saber Batiha

Autophagy modulators in type 2 diabetes: A new perspective

Journal of Diabetes 16(12) (2024)

Ayah Talal Zaidalkilani; Hayder M. Al‐kuraishy; Esraa H. Fahad; Ali I. Al‐Gareeb; Yaser Hosny Ali Elewa; Mahmoud Hosny Zahran; Athanasios Alexiou; Marios Papadakis; Ammar AL‐Farga; Gaber El‐Saber Batiha

PDE5 inhibitors: breaking new grounds in the treatment of COVID-19

Drug Metabolism and Personalized Therapy 38(4) (2024)

Ryan Varghese; Gargi Digholkar; Jainam Karsiya; Sahil Salvi; Jeenam Shah; Dileep Kumar; Rohit Sharma

Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19

Scientific Reports 13(1) (2023)

Hayder M. Al-kuraishy; Ali I. Al-Gareeb; Sumaiah J. Alarfaj; Rasha Khalifah Al-Akeel; Hani Faidah; Maisra M. El-Bouseary; Jean-Marc Sabatier; Michel De Waard; Thanaa A. El-Masry; Gaber El-Saber Batiha

SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19

Immunity, Inflammation and Disease 11(5) (2023)

Hayder M. Al‐kuraishy; Nawar R. Hussien; Marwa S. Al‐Niemi; Esraa H. Fahad; Ali K. Al‐Buhadily; Ali I. Al‐Gareeb; Sadiq M. Al‐Hamash; Christos Tsagkaris; Marios Papadakis; Athanasios Alexiou; Gaber El‐Saber Batiha

The Important Role of Interleukin-2 in COVID-19

Journal of Immunology Research 2023 (2023)

Leila Ghanbari Naeini; Laleh Abbasi; Farzaneh Karimi; Pajman Kokabian; Fahimeh Abdi Abyaneh; Delaram Naderi; Weicheng Hu

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons

Inflammopharmacology 30(3) (2022)

Hayder M. Al-kuraishy; Ali I. Al-Gareeb; Luay Alkazmi; Ola A. Habotta; Gaber El-Saber Batiha

SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway

Cell Stress and Chaperones 28(6) (2023)

Rabab S. Hamad; Hayder M. Al-kuraishy; Athanasios Alexiou; Marios Papadakis; Eman A. Ahmed; Hebatallah M. Saad; Gaber El-Saber Batiha